77 related articles for article (PubMed ID: 2522341)
1. Decrease in a proenkephalin peptide in cerebrospinal fluid in Huntington's disease and progressive supranuclear palsy.
Iadarola MJ; Mouradian MM
Brain Res; 1989 Feb; 479(2):397-401. PubMed ID: 2522341
[TBL] [Abstract][Full Text] [Related]
2. Enkephalin-containing polypeptides in human cerebrospinal fluid.
Nyberg F; Nylander I; Terenius L
Brain Res; 1986 Apr; 371(2):278-86. PubMed ID: 2870778
[TBL] [Abstract][Full Text] [Related]
3. Comparative immunohistochemical demonstration of peptide F- and other enkephalin-containing neurons in the enteric nervous system of the rat.
Wang YN; Wyatt RJ
Synapse; 1987; 1(2):208-13. PubMed ID: 3333199
[TBL] [Abstract][Full Text] [Related]
4. Peptides derived from prodynorphin are decreased in basal ganglia of Huntington's disease brains.
Dawbarn D; Zamir N; Waters CM; Hunt SP; Emson PC; Brownstein MJ
Brain Res; 1986 Apr; 372(1):155-8. PubMed ID: 2871898
[TBL] [Abstract][Full Text] [Related]
5. Opioid peptides in Huntington's disease: alterations in prodynorphin and proenkephalin system.
Seizinger BR; Liebisch DC; Kish SJ; Arendt RM; Hornykiewicz O; Herz A
Brain Res; 1986 Jul; 378(2):405-8. PubMed ID: 2873872
[TBL] [Abstract][Full Text] [Related]
6. Brain neuropeptides in progressive supranuclear palsy.
Taquet H; Javoy-Agid F; Mauborgne A; Benoliel JJ; Agid Y; Legrand JC; Hamon M; Cesselin F
Brain Res; 1987 May; 411(1):178-82. PubMed ID: 2440513
[TBL] [Abstract][Full Text] [Related]
7. The distribution of proenkephalin-derived peptides in the central nervous system of turtles.
Reiner A
J Comp Neurol; 1987 May; 259(1):65-91. PubMed ID: 3294930
[TBL] [Abstract][Full Text] [Related]
8. Proenkephalin A 119-159, a stable proenkephalin A precursor fragment identified in human circulation.
Ernst A; Köhrle J; Bergmann A
Peptides; 2006 Jul; 27(7):1835-40. PubMed ID: 16621157
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington's and Parkinson's disease.
Barschke P; Abu-Rumeileh S; Al Shweiki MHDR; Barba L; Paolini Paoletti F; Oeckl P; Steinacker P; Halbgebauer S; Gaetani L; Lewerenz J; Ludolph AC; Landwehrmeyer GB; Parnetti L; Otto M
J Neurol; 2022 Sep; 269(9):5136-5143. PubMed ID: 35737109
[TBL] [Abstract][Full Text] [Related]
10. Elevation of Proenkephalin 143-183 in Cerebrospinal Fluid in Moyamoya Disease.
Yokoyama K; Maruwaka M; Yoshikawa K; Araki Y; Okamoto S; Sumitomo M; Kawamura A; Sakamoto Y; Shimizu K; Izumi T; Wakabayashi T
World Neurosurg; 2018 Jan; 109():e446-e459. PubMed ID: 29030229
[TBL] [Abstract][Full Text] [Related]
11. Tissue kallikrein processes small proenkephalin peptides.
Mindroiu T; Carretero OA; Walz D; Scicli AG
Biochim Biophys Acta; 1991 Jan; 1076(1):9-14. PubMed ID: 1986798
[TBL] [Abstract][Full Text] [Related]
12. Assay of preproenkephalin A processing enzymes in human lumbar cerebrospinal fluid.
Kaneko T; Wood G; Crouch WL; Desiderio DM
Anal Biochem; 1993 Nov; 215(1):45-53. PubMed ID: 8297014
[TBL] [Abstract][Full Text] [Related]
13. Initial letter and semantic category fluency in Alzheimer's disease, Huntington's disease, and progressive supranuclear palsy.
Rosser A; Hodges JR
J Neurol Neurosurg Psychiatry; 1994 Nov; 57(11):1389-94. PubMed ID: 7964817
[TBL] [Abstract][Full Text] [Related]
14. Analysis of proenkephalin A, proopiomelanocortin and protachykinin neuropeptides in human lumbar cerebrospinal fluid by reversed-phase high-performance liquid chromatography, radioimmunoassay and enzymolysis.
Harajiri S; Wood G; Desiderio DM
J Chromatogr; 1992 Mar; 575(2):213-22. PubMed ID: 1629297
[TBL] [Abstract][Full Text] [Related]
15. Proenkephalin A and proopiomelanocortin peptides in human cerebrospinal fluid.
Liu DX; Wood GW; Desiderio DM
J Chromatogr; 1990 Sep; 530(2):235-52. PubMed ID: 1964161
[TBL] [Abstract][Full Text] [Related]
16. Developmental changes in rat adrenal enkephalin precursor: peptide ratio.
McMillian MK; Hudson PM; Lee DY; Thai L; Hung GH; Hong JS
Brain Res Dev Brain Res; 1993 Jan; 71(1):75-80. PubMed ID: 8432002
[TBL] [Abstract][Full Text] [Related]
17. Dynorphin levels in parkinsonian patients: Leu5-enkephalin production from either proenkephalin A or prodynorphin in human brain.
Taquet H; Javoy-Agid F; Giraud P; Legrand JC; Agid Y; Cesselin F
Brain Res; 1985 Aug; 341(2):390-2. PubMed ID: 2864101
[TBL] [Abstract][Full Text] [Related]
18. Preproenkephalin messenger RNA-containing neurons in striatum of patients with symptomatic and presymptomatic Huntington's disease: an in situ hybridization study.
Albin RL; Qin Y; Young AB; Penney JB; Chesselet MF
Ann Neurol; 1991 Oct; 30(4):542-9. PubMed ID: 1838677
[TBL] [Abstract][Full Text] [Related]
19. CSF galanin and neuropeptide Y immunoreactivity in progressive supranuclear palsy.
Litvan I; Berrettini WH; Atack JR; Chase TN
Acta Neurol Scand; 1992 Aug; 86(2):204-6. PubMed ID: 1384261
[TBL] [Abstract][Full Text] [Related]
20. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications.
Henderson JM; Carpenter K; Cartwright H; Halliday GM
Brain; 2000 Jul; 123 ( Pt 7)():1410-21. PubMed ID: 10869053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
